Type 1 Diabetes Research - Special Diabetes Program

Opportunities for Industry

Please visit the following websites for more information on opportunities for industry to participate in research supported by the Special Diabetes Program:

  • Small Business Program (SBIR/STTR): Open funding opportunities supported by the Special Diabetes Program will be posted on the Current Type 1 Diabetes Funding Opportunities website. For more information about the small business program, please see: General information on the NIH SBIR/STTR Program and NIDDK SBIR/STTR Program and Staff Contacts.
  • TrialNet  Exit Disclaimer Icon : a network of clinical centers, investigators, and core support facilities in the U.S. and Canada that supports the development and implementation of clinical trials of agents to slow the progression of type 1 diabetes in new-onset patients and to prevent type 1 diabetes in those at-risk of developing the disease.
  • Immune Tolerance Network  Exit Disclaimer Icon : an international consortium that evaluates promising tolerogenic treatment regimens in four clinical areas: islet transplantation, kidney transplantation, autoimmune diseases, and asthma and allergy diseases.
  • Diabetic Retinopathy Clinical Research Network (DRCR.net):   Exit Disclaimer Icon The mission of DRCR.net is to facilitate the conduct of multi-center clinical research of diabetic retinopathy, diabetic macular edema, and associated conditions.

JDRF  Exit Disclaimer Icon also has opportunities for industry partnerships.

Last Updated: 5/12/2012

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583